Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Invex Therapeutics Ltd. ( (AU:IXC) ) has provided an announcement.
Invex Therapeutics Ltd, trading under the ASX ticker IXC, has announced the lifting of its trading suspension following a material acquisition and a response to a price query from the ASX. This development is significant as it allows Invex Therapeutics to resume trading, potentially impacting its market position and providing new opportunities for stakeholders.
More about Invex Therapeutics Ltd.
Average Trading Volume: 69,125
Technical Sentiment Signal: Buy
Current Market Cap: A$12.02M
See more insights into IXC stock on TipRanks’ Stock Analysis page.